shares of ginkgo bioworks holdings closed down almost 12 after scorpion capital a research firm focused on short selling slammed the company as heavily reliant on related parties for the bulk of a key revenue source ginkgo stock ticker dna fell 116 at 1059 on wednesday ginkgo a leader in the emerging field of synthetic biology recently went public through a merger with a special purpose acquisition company soaring eagle acquisition in one of the largest spac combinations